Company Filing History:
Years Active: 2008
Title: **Innovative Contributions of Inventor Jahne Simon in Oral Drug Compliance Monitoring**
Introduction
Jahne Simon is an inventive mind residing in Angleton, TX, who has made significant contributions to the healthcare sector through his innovative solutions. With a focus on oral drug delivery systems, Simon has developed a technology that enhances drug compliance monitoring, which is crucial for patient treatment adherence.
Latest Patents
Jahne Simon holds a patent for a groundbreaking device titled "Oral drug compliance monitoring using radio frequency identification tags." This invention comprises a capsule, tablet, or pill designed to disperse in the gastrointestinal system. The unique aspect of this device involves an RFID (Radio Frequency Identification) tag incorporated within the medication. This tag operates through an antenna and features additional objects such as magnets or ferromagnetic materials that modulate the tag's response based on whether the drug has been ingested. Such a mechanism allows for real-time monitoring of the drug's dispersal in the body, providing invaluable data on patient compliance.
Career Highlights
Simon is affiliated with Dow Global Technologies LLC, where he applies his expertise to develop innovative technologies that improve pharmaceutical delivery systems. His work is pivotal in pushing the boundaries of how medication is monitored and ensuring it reaches the intended therapeutic outcomes.
Collaborations
Throughout his career, Jahne Simon has collaborated with talented professionals like Kristine L. Danowski and Larry S. Sun, contributing to a dynamic work environment that fosters creativity and innovation. This collaboration not only enhances the technological advancements at Dow Global Technologies but also supports the drive toward better healthcare solutions.
Conclusion
Jahne Simon's contributions to the field of oral drug compliance monitoring represent a significant advancement in patient care technology. His innovative patent not only showcases his technical abilities but also reflects his commitment to improving health outcomes through advanced drug delivery systems. With continued collaboration and innovation, Simon's work promises to inspire further developments in the pharmaceutical industry.